Pillstats
Rx only · Suspension · Auricular (Otic)

Neomycin Sulfate, Polymyxin B Sulfate And Hydrocortisone

Brands: Neomycin And Polymyxin B Sulfates And Hydrocortisone · Hydrocortisone + Neomycin Sulfate + Polymyxin B Sulfate

5 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US5 NDCs
5 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)8536
US makers5 labelers
Packages5
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.17$2.35$3.52$4.70Dec 2025Apr 2026Jul 2026
$3.774
Latest avg · Jul 22, 2026
-8%
Since Dec 17, 2025
5
Active US suppliers
40%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

13K25K38K50K2025 Q12025 Q22025 Q32025 Q42026 Q1
27K
Rx · 2026 Q1
268K
Units dispensed
-12%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it5 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager1SUPPLYING
Proficient Rx LPunknown1SUPPLYING
Sandoz Incunknown1SUPPLYING
A-S Medication Solutionsunknown1SUPPLYING
Preferred Pharmaceuticals Inc.unknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.